Hydralazine Hydrochloride Injection
Product Images NDC 71872-7145

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 71872-7145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial (401895h)

This is a description for the medication hydrALAZINE Hydrochloride Injection. The medication comes in a single dose vial prescription and has a strength of 20 mg per ml. The warning states that any unused portion should be discarded.*

FDA Label Image

Pdp (7145)

Hydralazine Hydrochloride Injection, USP is a sterile solution used for intramuscular or intravenous use. It comes in a 1 mL single-dose vial containing 20 mg/mL. The package contains a lot number and expiration date. Each mL of the solution contains 20 mg of hydralazine hydrochloride, 1036 mg of propylene glycol, and some other ingredients. It is manufactured by Fresenius Kb Lake Zurich. The solution must be stored properly, and unused portions need to be discarded. The packaging and distribution of the solution are handled by a medical purchasing solutions provider.*

FDA Label Image

Address (Fklz Address)

FDA Label Image

Structure (Hydralazine Hydrochloride Injection Usp Figure 1 Hydral Struc)

This appears to be a chemical compound description. The compound is identified as "CgHgNs * HCI" with a molecular weight of 196.64. However, the specific meaning of the characters and their intended use cannot be determined.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.